Search research articles
Contact Us
Filters
Showing results (61-70 of 87) with videos related to
Page
of 9
Sort By:
Transplantation and Cellular Therapy
|
May 17, 2026
Expert Panel Review and Practical Guidance on Biomarker Testing With Engineered Immune Effector Cells
Viktoria Blumenberg, Caroline Diorio, Jordan Gauthier, et al.
Blood Advances
|
October 21, 2021
Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysis
Mehdi Hamadani, Ajay K Gopal, Marcelo Pasquini, et al.
Blood
|
April 18, 2024
Human herpesvirus 6 reactivation and disease are infrequent in chimeric antigen receptor T-cell therapy recipients
Eleftheria Kampouri, Elizabeth M Krantz, Hu Xie, et al.
Nature Communications
|
April 6, 2026
Influence of B cell-lineage targeted CAR-T cell therapy on humoral immunity and vaccine-induced antibody response
Stosh Ozog, Elizabeth M Krantz, Karyn Tindbaek, et al.
The Lancet. Oncology
|
July 6, 2023
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial
Andrew J Cowan, Margot J Pont, Blythe D Sather, et al.
American Journal of Hematology
|
August 11, 2025
CD19 CAR T-Cell Therapy for Primary Mediastinal Large B-Cell Lymphoma: A CIBMTR Analysis
Jordan Gauthier, Kwang W Ahn, Jinalben Patel, et al.
Blood Advances
|
February 3, 2023
A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma
Geoffrey Shouse, Andy Kaempf, Max J Gordon, et al.
Blood Advances
|
January 17, 2025
Phase 1 study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult patients with B-ALL
Jordan Gauthier, Emily C Liang, Jennifer J Huang, et al.
Blood
|
April 19, 2022
Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL
Jordan Gauthier, Nicolas Gazeau, Alexandre V Hirayama, et al.
Current Research in Translational Medicine
|
September 13, 2018
Scoring System Based on Post-Transplant Complications in Patients after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Study from the SFGM-TC
Alexis Caulier, Elodie Drumez, Jordan Gauthier, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 87) with videos related to
Sort By:
Page
of 9
Transplantation and Cellular Therapy
|
May 17, 2026
Expert Panel Review and Practical Guidance on Biomarker Testing With Engineered Immune Effector Cells
Viktoria Blumenberg, Caroline Diorio, Jordan Gauthier, et al.
Blood Advances
|
October 21, 2021
Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysis
Mehdi Hamadani, Ajay K Gopal, Marcelo Pasquini, et al.
Blood
|
April 18, 2024
Human herpesvirus 6 reactivation and disease are infrequent in chimeric antigen receptor T-cell therapy recipients
Eleftheria Kampouri, Elizabeth M Krantz, Hu Xie, et al.
Nature Communications
|
April 6, 2026
Influence of B cell-lineage targeted CAR-T cell therapy on humoral immunity and vaccine-induced antibody response
Stosh Ozog, Elizabeth M Krantz, Karyn Tindbaek, et al.
The Lancet. Oncology
|
July 6, 2023
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial
Andrew J Cowan, Margot J Pont, Blythe D Sather, et al.
American Journal of Hematology
|
August 11, 2025
CD19 CAR T-Cell Therapy for Primary Mediastinal Large B-Cell Lymphoma: A CIBMTR Analysis
Jordan Gauthier, Kwang W Ahn, Jinalben Patel, et al.
Blood Advances
|
February 3, 2023
A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma
Geoffrey Shouse, Andy Kaempf, Max J Gordon, et al.
Blood Advances
|
January 17, 2025
Phase 1 study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult patients with B-ALL
Jordan Gauthier, Emily C Liang, Jennifer J Huang, et al.
Blood
|
April 19, 2022
Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL
Jordan Gauthier, Nicolas Gazeau, Alexandre V Hirayama, et al.
Current Research in Translational Medicine
|
September 13, 2018
Scoring System Based on Post-Transplant Complications in Patients after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Study from the SFGM-TC
Alexis Caulier, Elodie Drumez, Jordan Gauthier, et al.
Page
of 9